1.Long-term efficacy analysis of narrow-margin hepatectomy intraoperative radiotherapy for hepatocellular carcinoma
Mengyuan LI ; Yanling WU ; Liming WANG ; Fan WU ; Shulian WANG ; Yueping LIU ; Yongwen SONG ; Ning LI ; Yuan TANG ; Hao JING ; Hui FANG ; Ningning LU ; Shunan QI ; Zhuanbo YANG ; Siye CHEN ; Yexiong LI ; Jianxiong WU ; Qinfu FENG ; Yirui ZHAI ; Bo CHEN
Cancer Research and Clinic 2025;37(5):343-350
Objective:To investigate the long-term efficacy, safety and prognostic factors of intraoperative radiotherapy (IORT) for narrow-margin (resection margin < 1 cm) hepatectomy in patients with hepatocellular carcinoma (HCC) during radical surgery.Methods:A retrospective cohort study was conducted. The data of primary HCC patients undergoing radical surgery and narrow-margin hepatectomy IORT in the Cancer Hospital of the Chinese Academy of Medical Sciences from November 2009 to February 2019 were collected. IORT applied 6 MeV or 9 MeV electron beams and a single irradiation was given to the margin. Kaplan-Meier method was used for the overall survival (OS) and disease-free survival (DFS) analysis; log-rank test was used for survival comparison among subgroups. The recurrence patterns and adverse reactions were recorded. Univariate and multivariate Cox proportional hazards models were used to analyze the factors influencing the OS and DFS.Results:A total of 64 patients were enrolled, with the median age [ M ( Q1, Q3)] of 57 years (49, 63) years. All patients included 55 males (85.9%) and 9 females (14.1%). The median dose of IORT was 15 Gy (range: 12-17 Gy). The median follow-up time was 83.3 (64.4, 91.9) months. The 1-year, 3-year, 5-year, 7-year, 10-year OS rates were 90.4%, 80.6%, 75.5%, 71.4% and 47.6%, respectively; the 1-year, 3-year, 5-year, 7-year,10-year DFS rates were 77.8%, 68.1%, 59.6%, 57.6% and 38.4%, respectively. Univariate Cox regression analysis indicated that preoperative serum alpha-fetoprotein (AFP) > 400 ng/ml was an independent risk factor for poor OS (> 400 ng/ml vs. ≤ 400 ng/ml: HR = 6.57, 95% CI: 2.16-19.96, P < 0.001), while not the independent influencing factor of poor DFS ( HR = 1.71, 95% CI: 0.65-4.52, P = 0.277). The age ≤ 60 years or not, gender, viral hepatitis or not, American Joint Committee on Cancer stage, tumor diameter (> 5 cm or not), tumor number, degree of tumor differentiation, microvascular invasion or not, microsatellite nodules or not, anatomical liver resection or not, and the dose of IORT ≤15 Gy or not were not the independent influencing factors of poor OS and DFS (all P > 0.05). Kaplan-Meier method analysis showed that patients with preoperative serum AFP ≤ 400 ng/ml (48 cases) had better OS compared with those with preoperative serum AFP>400 ng/ml (16 cases) (5-year OS rate: 84.8% vs. 44.9%; 7-year OS rate: 79.9% vs.37.4%), and the difference was statistically significant ( P = 0.002). There was no statistically significant difference in the DFS between the 2 groups ( P = 0.134). During the follow-up, 28 patients (43.8%) relapsed, including 17 cases (26.6%) of early recurrence and 11 cases (17.2%) of late recurrence. No marginal recurrence was observed. There were 22 cases (34.4%) of intrahepatic recurrence alone, 2 cases (3.1%) of extrahepatic recurrence and 4 cases (6.3%) of stimutaneous recurrence inside and outside the liver. The 1-, 3-, 5- and 7-year cumulative recurrence rates inside the liver were 19.0%, 27.2%, 37.4% and 39.3% respectively, and the cumulative recurrence rates outside the liver were 6.4%, 8.0%, 9.6% and 9.6% respectively. There were no adverse reactions above grade 3 in the entire group. There were no surgery-related deaths within 30 d after the operation, and no radiation-induced liver disease occurred. Conclusions:Narrow-margin IORT helps HCC patients receiving hepatectomy to achieve favorable long-term survival and adverse reactions are tolerable. It can be used as a safe and effective adjuvant therapy alternative.
2.Development and Validation of a Predictive Model for Heart Failure in the People with Hypertension
Mengyuan WU ; Zichen DU ; Jiao LI
Journal of Medical Research 2025;54(4):77-83
Objective To establish and validate a risk model for predicting heart failure(HF)in patients with hypertension.Methods The clinical data of 1500 patients with hypertension in Department of Cardiology of Tianjin Union Medical Center from January 2019 to December 2021 were retrospectively collected.The dataset was randomly partitioned into a training set(n=1050)and a valida-tion set(n=450)at a ratio of 7∶3.Then,the patients of training set were segmented into heart failure group(n=144)or non-heart failure group(n=906).The univariate Logistic regression,least absolute shrinkage and selection operator(LASSO)regression model and multivariate Logistic regression analysis were used for screening the risk factors and developing model.The R software was used to con-struct a nomogram.The discrimination ability of the model was determined by the area under the receiver operating characteristic curve(AUC),the calibration degree was evaluated by the calibration plot and Hosmer-Lemeshow goodness-of-fit test.Decision curve analy-sis(DCA)was performed to assess the clinical utility.Results This study showed that age,coronary heart disease,uric acid(UA),red blood cell distribution width(RDW),blood urea nitrogen/albumin ratio(BAR)and neutrophil to lymphocyte ratio(NLR)are inde-pendent predictors of the development of HF in patients with hypertension.A predictive model was constructed using the above six predic-tive factors.In the training set,the model had an AUC value of 0.864(95%CI;0.831-0.896),Hosmer-Lemeshow goodness of fit test showedx2=10.29,P=0.25.In the validation set,the AUC value was 0.842(95%CI:0.794-0.891),Hosmer-Lemeshow goodness of fit test showedx2=10.48,P=0.23.The clinical decision analysis also showed that the nomogram model had a better clinical perform-ance and could bring net clinical benefits to the patients.Conclusion This study successfully constructs a predictive model for the risk of HF in adults with hypertension and it can effectively identify patients at high risk of HF and formulate targeted intervention measures,thereby providing a basis for performing early prevention and treatment and improving prognosis.
3.Influencing factors of overweight and obesity among primary and secondary school students in Pudong New Area of Shanghai
Mengyuan DING ; Ling HUANG ; Qian WU ; Chao LIANG ; Yuxin JIANG ; Chunhua GU
Journal of Public Health and Preventive Medicine 2025;36(6):142-146
Objective To investigate the status and influencing factors of overweight and obesity among primary and secondary school students in Pudong New Area of Shanghai, and to provide reference for formulating obesity-related intervention strategies for school-age children. Methods Stratified cluster random sampling method was used to conduct a questionnaire survey among primary and secondary school students in Pudong New Area. The overweight and obesity rate was calculated according to the Chinese health industry standard, and the risk factors of overweight and obesity in children and adolescents of different school age groups were analyzed by logistic regression. Results The overweight and obesity rate (25.3%) of primary and secondary school students in Pudong New Area exceeded the national average level. In primary school group, male, sleep time ≥ 8h per day, water intake ≥ 1200 mL per day, and the presence of mobile food stalls around the school were the risk factors for overweight and obesity. Daily extracurricular exercise time of 30 minutes to 2 hours was a protective factor. In junior high school group, male and electronic product use time of ≥ 2h per day were the risk factors for overweight and obesity. The daily extracurricular exercise time of 1 to 2 hours was a protective factor. In high school group, drinking water ≥1200mL per day was a risk factor for overweight and obesity. Eating breakfast every day for the past week was a protective factor. Conclusion Group intervention targeting overweight and obese school-age children, while changing corresponding unhealthy habits according to different school age groups, is crucial for weight loss in school-age children.
4.Construction of a predictive model for the risk of cesarean scar diverticula formation after cesarean delivery based on multifactorial Logistic regression
Mengyuan Zhang ; Ye He ; Yuanyuan Wu ; Jing Wang
Acta Universitatis Medicinalis Anhui 2025;60(7):1297-1304
Objective:
To screen the risk factors of cesarean scar diverticula ( CSD) after cesarean section and to construct a risk prediction model.
Methods:
491 cases of mothers who underwent cesarean section were recruited as the study subjects,and the data from the database of negative ultrasound of mothers who returned to the hospital 12 months after operation were collected,and the dataset was randomly divided into the training set and the test group according to 7 ∶ 3 ; the variables were screened to obtain the risk factors of CSD and the risk prediction model was constructed by the use of least absolute shrinkage and selection operator (LASSO) ; the variables were screened using the LASSO to obtain the characteristic variables,and the characteristic variables were analyzed by multifacto- rial logistic regression analysis,and the nomogram prediction model was constructed by using the R software.
Results:
A total of 491 cases of sample data were included,including 344 cases in the training set and 147 cases in the test set ; feature variables were screened by LASSO,and ten-fold cross-validation was used.Five variables were finally screened : number of cesarean deliveries,number of years between two cesarean deliveries,24-hour hemorrhage,operation time and uterine position(P<0. 05) .The accuracy of the decision analysis curves for inter- nal evaluation and internal validation of the CSD risk prediction model constructed using it was high ; the AUC (95% CI) of the diagnostic model in the training set and the test set were 0. 75 (0. 71-0. 80) and 0. 79 (0. 71 - 0. 87) ,respectively.
Conclusion
The risk prediction model established using the LASSO cross-validation algo- rithm has good predictive value for the occurrence of postpartum scar diverticula,which deserves clinical attention.
5.Advance in drug therapy for acute kidney injury
Xiaohe CHEN ; Mengyuan WU ; Wenyong XIA ; Xuhua GE
International Journal of Pediatrics 2025;52(5):315-320
Acute kidney injury(AKI)is a clinical syndrome characterized by a rapid decline in renal function. Treatment strategies for AKI primarily focus on treating the underlying disease,providing supportive care,and preventing complications. However,the prognosis remains poor due to the lack of targeted drug therapies.In recent years,with a deeper understanding of the pathophysiological mechanisms of AKI,numerous new drugs and therapeutic methods have emerged and are currently under evaluation. This review aims to thoroughly analyze the latest advancements in AKI drug therapy,covering the development of targeted drugs,innovative applications of nanomedicines,and new breakthroughs and expansions in the use of traditional drugs in the treatment of AKI,in order to provide new ideas and strategies for clinical treatment.
6.Pristimerin induces Noxa-dependent apoptosis by activating the FoxO3a pathway in esophageal squamous cell carcinoma.
Mengyuan FENG ; Anjie ZHANG ; Jingyi WU ; Xinran CHENG ; Qingyu YANG ; Yunlai GONG ; Xiaohui HU ; Wentao JI ; Xianjun YU ; Qun ZHAO
Chinese Journal of Natural Medicines (English Ed.) 2025;23(5):585-592
Pristimerin, which is one of the compounds present in Celastraceae and Hippocrateaceae, has antitumor effects. However, its mechanism of action in esophageal squamous cell carcinoma (ESCC) remains unclear. This study aims to investigate the efficacy and mechanism of pristimerin on ESCC in vitro and in vivo. The inhibitory effect of pristimerin on cell growth was assessed using trypan blue exclusion and colony formation assays. Cell apoptosis was evaluated by flow cytometry. Gene and protein expressions were analyzed through quantitative reverse transcription-polymerase chain reaction (qRT-PCR), Western blotting, and immunohistochemistry. RNA sequencing (RNA-Seq) was employed to identify significantly differentially expressed genes (DEGs). Cell transfection and RNA interference assays were utilized to examine the role of key proteins in pristimerin?s effect. Xenograft models were established to evaluate the antitumor efficiency of pristimerin in vivo. Pristimerin inhibited cell growth and induced apoptosis in ESCC cells. Upregulation of Noxa was crucial for pristimerin-induced apoptosis. Pristimerin activated the Forkhead box O3a (FoxO3a) signaling pathway and triggered FoxO3a recruitment to the Noxa promoter, leading to Noxa transcription. Blocking FoxO3a reversed pristimerin-induced Noxa upregulation and cell apoptosis. Pristimerin treatment suppressed xenograft tumors in nude mice, but these effects were largely negated in Noxa-KO tumors. Furthermore, the chemosensitization effects of pristimerin in vitro and in vivo were mediated by Noxa. This study demonstrates that pristimerin exerts an antitumor effect on ESCC by inducing AKT/FoxO3a-mediated Noxa upregulation. These findings suggest that pristimerin may serve as a potent anticancer agent for ESCC treatment.
Forkhead Box Protein O3/genetics*
;
Humans
;
Apoptosis/drug effects*
;
Esophageal Squamous Cell Carcinoma/physiopathology*
;
Esophageal Neoplasms/physiopathology*
;
Pentacyclic Triterpenes
;
Animals
;
Cell Line, Tumor
;
Proto-Oncogene Proteins c-bcl-2/genetics*
;
Mice
;
Signal Transduction/drug effects*
;
Mice, Nude
;
Cell Proliferation/drug effects*
;
Triterpenes/pharmacology*
;
Xenograft Model Antitumor Assays
;
Mice, Inbred BALB C
;
Male
;
Gene Expression Regulation, Neoplastic/drug effects*
7.Association between edentulism and the risk of social isolation in middle-aged and older adults
DUAN Chengwei ; LUO Mingyi ; FAN Chenrui ; XU Jialei ; MUHETAER Tureke ; XU Mengyuan ; WAN Weiping ; LIAO Haiqing ; WU Zeni
Journal of Prevention and Treatment for Stomatological Diseases 2025;33(12):1070-1077
Objective:
To investigate the association between edentulism and the risk of social isolation in middle-aged and elderly populations, provide empirical evidence for formulating social isolation prevention and intervention policies targeting edentulous middle-aged and elderly populations.
Methods:
Data were derived from the baseline survey (2011) and three follow-ups (2013, 2015, 2018) of the China Health and Retirement Longitudinal Study (CHARLS). Participants were enrolled in the follow-up from the baseline. Those identified as socially isolated in any of the follow-up surveys conducted in 2013, 2015, or 2018 were considered to have reached the endpoint; otherwise, the follow-up was continued until the end of the 2018 survey; 9 870 individuals were ultimately included. Subjects were grouped by edentulism status. Chi-square test and multivariate Cox regression analysis were performed using Stata 17.0.
Results:
During a median follow-up of 6.54 years, 1 800 cases of social isolation occurred, with an incidence rate of 18.23%(17.47%~18.99%). Multivariate Cox regression showed that edentulism was associated with an increased risk of social isolation (HR=1.21, 95% CI: 1.03-1.42) after adjusting for confounders. Subgroup analysis revealed population heterogeneity. Sensitivity analyses confirmed the stability of the results.
Conclusion
Edentulism is associated with an increased risk of social isolation in middle-aged and elderly adults.
8.ARID1A IDR targets EWS-FLI1 condensates and finetunes chromatin remodeling.
Jingdong XUE ; Siang LV ; Ming YU ; Yixuan PAN ; Ningzhe LI ; Xiang XU ; Qi ZHANG ; Mengyuan PENG ; Fang LIU ; Xuxu SUN ; Yimin LAO ; Yanhua YAO ; Juan SONG ; Jun WU ; Bing LI
Protein & Cell 2025;16(1):64-71
9.Discovery of toad-derived peptide analogue targeting ARF6 to induce immunogenic cell death for immunotherapy of hepatocellular carcinoma.
Dihui XU ; Xiang LV ; Meng YU ; Ao TAN ; Jiaojiao WANG ; Xinyi TANG ; Mengyuan LI ; Wenyuan WU ; Yuyu ZHU ; Jing ZHOU ; Hongyue MA
Journal of Pharmaceutical Analysis 2025;15(3):101038-101038
Image 1.
10.The impact of prophylactic cranial irradiation on the prognosis of patients with limited-stage small cell lung cancer
Xiao HU ; Mengyuan CHEN ; Shuohan ZHENG ; Qing WU ; Yue KONG ; Fang PENG ; Qun ZHANG ; Chao ZHENG ; Yong BAO ; Yujin XU ; Ming CHEN
Chinese Journal of Radiation Oncology 2025;34(3):249-255
Objective:To evaluate the impact of prophylactic cranial irradiation (PCI) on the prognosis of patients with limited-stage small cell lung cancer (SCLC) in the era of widespread application of MRI.Methods:Clinical data were collected from an open-lable prospective clinical trial on thoracic radiotherapy target volumes for limited-stage SCLC conducted in Sun Yat-sen University Cancer Center and Zhejiang Cancer Hospital between June 2002 and January 2017. In this study, patients who achieved complete remission (CR) or partial remission (PR) after definitive chemoradiotherapy (CRT) were retrospectively analyzed. Stratified analysis was performed according to different clinical efficacies. Patients were divided into different groups according to whether PCI was conducted or not. Survival analysis of patients was carried out. Survival data were calculated by Kaplan-Meier method, and Cox proportional hazards model was applied for multivariate prognostic analysis.Results:Among 309 patients with limited-stage SCLC who received CRT, 133 patients achieved CR and 140 cases obtained PR. These 273 patients were enrolled in this study. Among 133 patients with CR, 29 of them did not receive PCI, and 89 (85.6%) of the remaining 104 patients receiving PCI underwent brain MRI to exclude brain metastasis (BM) before PCI. With a median follow-up time of 22.1 months, the cumulative BM rates were 18.3% and 37.9% in patients who received or did not receive PCI ( P=0.020). The median overall survival (OS) was 30.2 and 30.5 months, and the 1-, 3- and 5-year OS rates were 93.3%, 41.9%, 27.7% and 82.8%, 44.8%, 40.8%, respectively ( P=0.910). Multivariate analysis indicated that baseline Karnofsky performance status (KPS) = 90 was a favorable independent prognostic factor for OS in CR patients ( HR=0.93, 95% CI: 0.89-0.98, P=0.006). Among 140 patients achieving PR, 52 cases did not receive PCI and 80 (90.9%) of the remaining 88 patients received brain MRI before PCI. With a median follow-up time of 18.9 months, the cumulative BM rates were 10.2% and 44.2% ( P<0.001). The median OS was 26.0 and 18.0 months, and the 1-, 3-, and 5-year OS rates were 86.4%, 37.9%, 32.2% and 75.0%, 17.3%, 10.8%, respectively ( P=0.001). Baseline KPS = 90 ( HR=0.93, 95% CI: 0.89-0.97, P=0.001) and PCI ( HR=0.54, 95% CI: 0.36-0.80, P=0.002) were favorable prognostic factors for OS in PR patients. Conclusions:PCI significantly reduces the incidence of BM and prolongs the OS in patients with limited-stage SCLC who achieve PR after CRT, but it fails to significantly prolong the OS of CR patients.


Result Analysis
Print
Save
E-mail